# FDA Inspection 1250227 - Raritan Pharmaceuticals, Inc. - April 02, 2025

Source: https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/1a844f99-5473-4890-a8bf-2c8de0080187
Source feed: FDA_Inspections

> FDA Inspection 1250227 for Raritan Pharmaceuticals, Inc. on April 02, 2025. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1250227
- Company Name: Raritan Pharmaceuticals, Inc.
- Inspection Date: 2025-04-02
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1037112 - 2018-01-08](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/f275a0be-8cda-446f-9c15-5566f69959dc)
- [FDA Inspection 995165 - 2016-10-20](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/779fe977-f104-48a2-84ec-2f8ccae976e3)
- [FDA Inspection 969785 - 2016-04-14](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/4e1f0a76-f5de-436c-9de0-36541b294bdc)
- [FDA Inspection 799355 - 2012-09-19](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/af765194-be49-48aa-836e-424e9af61645)
- [FDA Inspection 798953 - 2012-08-21](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/03248a1a-d694-4d0b-b656-3e883d512301)

Company: https://www.keypedia.com/companies/raritan-pharmaceuticals-inc/31d76ce5-e5b2-4f61-b7b5-daa1a81f7cf0

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248